Editorial: Migration Studies to Determine Risk and Cause of Inflammatory Bowel Disease

Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.14186
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Editorial: Inflammatory Bowel Disease Risk Reduction After Migration - Are Early Life Events Important?

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Editorial: Anxiety and Depression in Inflammatory Bowel Disease

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Does Eradication of Helicobacter Pylori Cause Inflammatory Bowel Disease?

Clinical Gastroenterology and Hepatology
HepatologyGastroenterology
2019English

Editorial: Treating Strictures in Inflammatory Bowel Disease

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Letter: Inflammatory Bowel Disease and Risk of Myocardial Infarction

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2020English

CD8+ T Cell Gene Expression Profiling to Determine Inflammatory Bowel Disease (IBD) Prognosis

Science-Business eXchange
2011English

Risk of Inflammatory Bowel Disease Following a Diagnosis of Irritable Bowel Syndrome

BMC Gastroenterology
MedicineGastroenterology
2012English

Editorial: Weighing the Global Risk of Cancer With Thiopurines in Inflammatory Bowel Disease-Authors' Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Editorial: Treating Strictures in Inflammatory Bowel Disease-Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy